Fexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
L. Perrigo Company is recalling 15,504 cartons of Fexofenadine Hydrochloride 180 mg tablets nationwide due to failed impurity and degradation specifications.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving failed chemical purity and degradation specifications in an over-the-counter medication. No illnesses or injuries have been reported, and the hazard is based on failed quality testing rather than confirmed harm.
Plain-English summary
L. Perrigo Company is recalling 15,504 cartons of Fexofenadine Hydrochloride 180 mg tablets nationwide in the United States. The affected product is identified by NDC 45802-847-78, Lot #2DR0351, with an expiration date of 12/23.
The recall was initiated because the product failed to meet impurity and degradation specifications. These specifications ensure the chemical purity and stability of the drug.
This recall affects consumers nationwide who obtained these tablets from retail locations. Fexofenadine Hydrochloride is an over-the-counter antihistamine used to treat allergy symptoms.
Consumers who have purchased this product should discontinue use and return it to their pharmacy. Healthcare providers and patients should contact Perrigo or the FDA with any questions about this recall.
The recalled product
- Product
- FEXOFENADINE HYDROCHLORIDE (FEXOFENADINE HYDROCHLORIDE)
- Brand
- FEXOFENADINE HYDROCHLORIDE
- Manufacturer
- L. Perrigo Company
- Affected units
- 15,504
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2DR0351
- Exp. date 12/23
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by L. Perrigo Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same brand · FEXOFENADINE HYDROCHLORIDE
- HighFexofenadine Hydrochloride Antihistamine Tablets Recalled for Microbial Contamination
FDA (Drugs) · 2024-01-31
Same manufacturer · L. Perrigo Company
See all →- HighFexofenadine Tablets Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Antihistamine Tablets Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same hazard · chemical impurity
See all →- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- HighDuloxetine Delayed-Release Capsules Recalled for Manufacturing Impurity Above Safe Limits
FDA (Drugs) · 2025-01-15
- HighDuloxetine antidepressant recall for chemical impurity above FDA limit
FDA (Drugs) · 2025-01-01
- HighMorphine Sulfate Extended-Release Tablets Recalled for Impurities and Degradation
FDA (Drugs) · 2024-11-13
- HighCinacalcet Tablets Recalled Due to Nitrosamine Impurity
FDA (Drugs) · 2024-11-06